Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lenvatinib”

525 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 525 results

Testing effectiveness (Phase 2)Study completedNCT03173560
What this trial is testing

Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Eisai Inc. 343
Not applicableStudy completedNCT02592356
What this trial is testing

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more
M.D. Anderson Cancer Center 23
Early research (Phase 1)Study completedNCT02198170
What this trial is testing

A Pharmacokinetic Study to Assess the Influence of Simultaneous CYP3A4 and P-glycoprotein Inhibition on E7080 Pharmacokinetics Following Single Dose Oral Administration of 5 mg E7080 to Healthy Volunteers

Who this might be right for
Healthy Volunteers
Eisai Inc. 18
Testing effectiveness (Phase 2)UnknownNCT05903456
What this trial is testing

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05195294
What this trial is testing

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaLiver Cancer, AdultLiver Cell Carcinoma
Lion TCR Pte. Ltd. 55
Testing effectiveness (Phase 2)Study completedNCT04193553
What this trial is testing

Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

Who this might be right for
Gastro Intestinal Stromal Tumour
Centre Leon Berard 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT05901194
What this trial is testing

Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Assistance Publique - Hôpitaux de Paris 25
Not applicableNot Yet RecruitingNCT07340502
What this trial is testing

TACE Versus HAIC, Combined With PD-1 Inhibitors and Lenvatinib for Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC
Tongji Hospital 364
Large-scale testing (Phase 3)Study completedNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 479
Large-scale testing (Phase 3)UnknownNCT05910970
What this trial is testing

Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation

Who this might be right for
Hepatocellular CarcinomaRecurrenceImmune Checkpoint Inhibitor
Guangxi Medical University 200
Large-scale testing (Phase 3)Looking for participantsNCT06201065
What this trial is testing

FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 200
Early research (Phase 1)UnknownNCT05225116
What this trial is testing

Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma
Beijing Tsinghua Chang Gung Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04586231
What this trial is testing

Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 747
Testing effectiveness (Phase 2)Ended earlyNCT05263492
What this trial is testing

Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer

Who this might be right for
Endometrial CancerMismatch Repair-ProficientRecurrent Endometrial Cancer
Virginia Commonwealth University 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT04008797
What this trial is testing

E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

Who this might be right for
Endometrial NeoplasmsNeoplasmsCarcinoma, Hepatocellular+2 more
Eisai Inc. 301
Large-scale testing (Phase 3)Study completedNCT04865289
What this trial is testing

Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study

Who this might be right for
Endometrial Neoplasms
Merck Sharp & Dohme LLC 130
Testing effectiveness (Phase 2)UnknownNCT05897268
What this trial is testing

Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)

Who this might be right for
Hepatocellular Carcinoma
Fudan University 25
Testing effectiveness (Phase 2)UnknownNCT04699071
What this trial is testing

Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)

Who this might be right for
AdenocarcinomasRecurrent Gynecological
National University Hospital, Singapore 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07537946
What this trial is testing

Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastases
Tongji Hospital 400
Testing effectiveness (Phase 2)Looking for participantsNCT05832827
What this trial is testing

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)

Who this might be right for
Untreated Advanced or Recurrent Thymic Carcinomas
National Cancer Center, Japan 35
Load More Results